Coronary Artery Disease Clinical Trials in Atlanta, Georgia
13 studies are recruiting for coronary artery disease in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…
- Stage
- Phase 2
- Ages
- 18 to 85
- Site
- Emory University, Atlanta, Georgia
- Locations
- 14 in total
- Run by
- XyloCor Therapeutics, Inc.
-
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Piedmont Heart Institute, Atlanta, Georgia
- Locations
- 19 in total
- Run by
- Supira Medical
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Emory University, Atlanta, Georgia
- Locations
- 18 in total
- Run by
- Weill Medical College of Cornell University
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Emory University, Atlanta, Georgia
- Locations
- 18 in total
- Run by
- Weill Medical College of Cornell University
-
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…
- Stage
- Not phased
- Ages
- Any age
- Site
- Emory University Hospital- Emory Heart and Vascular Center, Atlanta, Georgia
- Locations
- 48 in total
- Run by
- Minneapolis Heart Institute Foundation
-
SELUTION 4 De Novo Small Vessel IDE Trial
Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Atlanta VA, Atlanta, Georgia
- Locations
- 70 in total
- Run by
- M.A. Med Alliance S.A.
-
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Emory University Hospital Midtown, Atlanta, Georgia
- Locations
- 19 in total
- Run by
- Emory University
-
CTSN Embolic Protection Trial
This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.
- Stage
- Not phased
- Ages
- 60 and older
- Site
- Emory University, Atlanta, Georgia
- Locations
- 28 in total
- Run by
- Icahn School of Medicine at Mount Sinai
-
Prevail Global Study
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Emory University Hospital Midtown, Atlanta, Georgia
- Locations
- 51 in total
- Run by
- Medtronic Vascular
-
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Emory University, Atlanta, Georgia
- Locations
- 146 in total
- Run by
- Weill Medical College of Cornell University
-
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Emory University Hospital /Emory School of Medice, Atlanta, Georgia
- Locations
- 24 in total
- Run by
- Concept Medical Inc.
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…
- Stage
- Not phased
- Ages
- Any age
- Site
- Piedmont, Atlanta, Georgia
- Locations
- 72 in total
- Run by
- University of British Columbia
-
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Emory University, Atlanta, Georgia
- Locations
- 18 in total
- Run by
- Kardion Inc
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.